Press release
Tumor Necrosis Factor Alpha (TNF-a) Inhibitors - Pipeline Insights 2017
Tumor Necrosis Factor Alpha (TNF-a) Inhibitors - Pipeline Insights 2017
View details: https://www.arizton.com/reports/pharma-pipeline-analysis/tumor-necrosis-factor-alpha-tnf-a-inhibitors-pipeline-insights
Key players developing potential TNF-a drug candidates have been profiled in the report. Each of the company profile provides details such as company overview, business overview, financial overview, product portfolio, business strategies, and recent developments.
Scope
Report provides in-depth insights on active TNF-a inhibitors pipeline drug candidates
Extensive pipeline product coverage with demarcation by various stages of development from NDA filings to discovery.
Provides pipeline assessment by monotherapy, combination therapy products and route of administration
Provides comparative analysis of key marketed and pipeline TNF-a inhibitors
Coverage of detailed pipeline drug profiles which includes product description, chemical information, MOA, licensors & collaborators, development partner
The report analyses key players involved in clinical research and development of the TNF-a inhibitors
Coverage of key news related to TNF-a inhibitors including major mergers and acquisitions and all product development updates such as clinical trial progression updates, regulatory updates
Related Reports
1) Histone Deacetylase (HDAC) Inhibitors - Pipeline Insights 2017
https://www.arizton.com/reports/pharma-pipeline-analysis/histone-deacetylase-hdac-inhibitors-pipeline-insights
2) AKT Inhibitors - Pipeline Insights 2017
https://www.arizton.com/reports/pharma-pipeline-analysis/akt-inhibitors-pipeline
About Arizton
Arizton – Advisory and Intelligence is an innovation and quality-driven firm, which offers cutting-edge research solutions to clients across the world. We excel in providing comprehensive market intelligence reports and advisory and consulting services.
Arizton has gained a paramount standpoint in the market research arena as it offers top of the line solutions to clients to assess market landscape and to finalize foolproof business strategies. We are committed to provide inclusive market research reports and consulting services to clients from diversified industries including –Consumer Goods & Retail Technology, Automotive and Mobility, Smart Tech, Healthcare and Lifesciences, Industrial Machinery, Chemicals and Materials, IT and Media, Logistics and Packaging
Arizton comprises a team of exuberant and well-experienced analysts who have mastered in generating incisive reports. Our specialist analysts possess exemplary skills in market research. We train our team in advanced research practices, techniques, and ethics to outperform in fabricating impregnable research reports.
Arizton Advisory & Intelligence
Chicago, Illinois, 60605
Mail: enquiry@arizton.com
Call: +1-312-465-7864
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Tumor Necrosis Factor Alpha (TNF-a) Inhibitors - Pipeline Insights 2017 here
News-ID: 774108 • Views: …
More Releases from Arizton Advisory & Intelligence
Exclusive Focus Insight Report by Arizton Predicts, the US Pool Maintenance and …
According to Arizton's latest focus research report, the US pool maintenance and cleaning service market is growing at a CAGR of 4.17% during 2023-2029.
To Know More, Click: https://www.focusreports.store/report/us-pool-maintenance-and-cleaning-services-market
The market is growing significantly due to advances in the pool technology, shift toward sustainability practices, rising popularity of subscription-based pool services, growing awareness of chemical balancing for above-ground pools, the growing demand for pool opening and closing services, the increasing demand…
The US Neonatal Incubators Market to Reach $121.11 Million by 2029 - Exclusive F …
According to Arizton's latest focus insight report, the US Neonatal incubators market is growing at a CAGR of 3.57% during 2023-2029.
To Know More, Click: https://www.focusreports.store/report/us-neonatal-incubators-market
The infant incubator market is highly fragmented, with many producers in the US. To meet the surging consumer demand and expand their customer base, these companies are implementing various tactics such as mergers & acquisitions, partnerships & collaborations, and new product launches. Owing to the…
The US Sleep Supplements Market to Reach $1.45 Billion by 2029 - Exclusive Focus …
According to Arizton's latest research report, the US sleep supplements market is growing at a CAGR of 5.97% during 2023-2029.
To Know More, Download the Free Sample Report: https://www.focusreports.store/report/us-sleep-supplements-market
The US sleep supplements market is growing significantly due to a surge in online sales and increasing demand for plant-based options. Lifestyle factors such as stress, irregular sleep patterns, and changing demographics, notably an aging population and health-conscious millennials, are driving this…
The Sale of Thailand Construction Equipment Market to Reach 22,586 Units by 2029 …
According to Arizton's latest research report, the Thailand construction equipment market is growing at a CAGR of 5.77% during 2023-2029.
To Know More, Click: https://www.arizton.com/market-reports/thailand-construction-equipment-market
Market Trends:
In January 2024, Thailand announced the launch of lithium production within two years from a new mine in the southwest part of the country. This aim is to support its goal of becoming a major regional hub for Electric Vehicle (EV) production. Establishing lithium…
More Releases for Inhibitors
Immune Checkpoint Inhibitors Market: Current Evidence And Future Perspectives Of …
Stratagem Market Insights delivers key insights for the Immune Checkpoint Inhibitors market in its published report, which include global industry analysis, Size, Growth, Opportunities, Emerging Trends, Challenges, and Geographic Regions over the forecast period (2021-2028). In terms of revenue, the global Immune Checkpoint Inhibitors market is projected to grow at a CAGR of XX% during the forecast period, owing to several factors about which SMI offers detailed insights and forecasts…
Vesicular Monoamine Transporter-2 Inhibitors (VMAT2 Inhibitors) Market to Regist …
Vesicular monoamine transporter 2 (VMAT2) is a membrane-embedded protein that is responsible for uptake of monoamines neurotransmitters such as dopamine, serotonin, norepinephrine, and histamines into the synaptic vesicles in monoaminergic neurons. Vesicular monoamine transporter proteins 2 are expressed in the central nervous system (CNS) and plays the crucial role in the signaling process between the monoamine neurons. VMAT2 is the only transporter that carries the cytoplasmic dopamine into the vesicles.…
Crude Oil Flow Improvers Market by Type (Paraffin Inhibitors, Asphaltene Inhibit …
Global Crude Oil Flow Improvers Market was valued at $1,282 million in 2016, and is anticipated to reach $1,920 million, growing at a CAGR of 5.7% from 2017 to 2023. Crude oil is one of the most actively traded commodities with a stable growth rate globally. It is extracted from remote locations and needs to be transported through pipelines. Transportation of crude oil via pipeline is relatively difficult, owing to…
Immune Check Point Inhibitors Market Immune Check Point Inhibitors Clinical Pipe …
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990
Report Table of Contents
Immune Checkpoint Inhibitors- Introduction to Next Generation Cancer Immunotherapy
1.1 Overview
1.2 History- From Tragedy to Breakthrough
Major Immune Checkpoints Proteins
2.1 Role of Cytotoxic T lymphocyte Antigen-4 (CTLA-4) in Cancer Development
2.2 Role of Programed Cell Death Protein 1 (PD1) in Cancer Development
Mechanism of Action of Immune Checkpoint Inhibitors
3.1 Cytotoxic T lymphocyte Antigen-4…
Global Immune Check Point Inhibitors Market & Immune Check Point Inhibitors Clin …
Immunotherapy represents a paradigm shift in oncology therapy along the multiple fronts. Although, targeted therapy upgrades the underlying signaling defect which results in oncogenesis within the tumor. The immune checkpoint blockade is fundamentally a therapy which directed at the patient's native immune system to tilt the immune homeostasis away from self-tolerance towards cytotoxicity, with the goal of inducing antitumor immunity.
The immune checkpoint inhibitors such as ipilimumab, nivolumab and pembrolizumab…
Tumor Necrosis Factor Inhibitors Market & TNF Inhibitors Clinical Pipeline Outlo …
The search for the effective therapeutic approaches in the modulation of the TNF has been focus of the research efforts. Approximately 1 Million people in the worldwide either undergoing the treatment or have been treated with the TNF inhibitors which are available in the pharmaceutical market which surrounding the indications that include the rheumatoid arthritis, psoriatic arthritis, psoriasis and inflammatory bowel diseases.
The neutralization of the TNF signaling can be achieved…
